https://actgnetwork.org/clinical-trial/a5397-hvtn-603a-phase-2a-2b-study-evaluating-safety-immunogenicity-and-therapeutic-efficacy-of-id93-gla-se-vaccination-in-participants-with-rifampicin-susceptible-pulmonary-tb/
A5397/HVTN 603:A Phase 2a/2b Study Evaluating Safety, Immunogenicity, and Therapeutic Efficacy of...